hepatitis

The test is performed on the company's AmpiProbe platform, and the approval expands Enzo's offering of infectious disease tests in New York.

Medcis Pathlabs and its associates and attendees will buy Co-Diagnostics' tests for hepatitis B, hepatitis C, HIV, and human papillomavirus.

Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now.

The test enables donor screening laboratories to use PCR-based diagnostic technology to screen donated blood and plasma.

Professional, molecular, and tissue diagnostics sales continued to grow during the first three quarters, while diabetes care sales remained in decline.

This Week in Nature

In Nature this week: modified CRISPR approach changes single nucleotides, new salmon genome assembly, and more.

Roche's molecular diagnostics business, which makes up 17 percent of its overall diagnostics sales, grew 11 percent, driven by virology testing and sequencing.

The virus, known as HPgV-2, was detected in blood samples from individuals with concurrent hepatitis C virus infections.

It's the first approved test to feature the firm's proprietary AmpiProbe nucleic acid amplification and detection platform.

This Week in PNAS

In PNAS this week: decreased DOCK4 expression in myelodysplastic syndromes plus anemia, hepatitis A evolution, and more.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.